Elevance Health Inc. (0HG8.L)
USD 427.08
(-2.57%)
USD 427.08
(-2.57%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 47.01 Billion USD | 17.66% |
| 2022 | 39.95 Billion USD | 12.38% |
| 2021 | 35.99 Billion USD | 13.13% |
| 2020 | 33.82 Billion USD | 10.46% |
| 2019 | 22.42 Billion USD | 10.98% |
| 2018 | 20.21 Billion USD | 2.29% |
| 2017 | 17.8 Billion USD | 6.1% |
| 2016 | 18.14 Billion USD | 7.21% |
| 2015 | 18.12 Billion USD | 7.15% |
| 2014 | 17.06 Billion USD | 4.01% |
| 2013 | 14.88 Billion USD | 15.09% |
| 2012 | 13.32 Billion USD | 1.65% |
| 2011 | 13.15 Billion USD | 3.25% |
| 2010 | 13.91 Billion USD | -9.57% |
| 2009 | 14.65 Billion USD | 6.17% |
| 2008 | 14.24 Billion USD | 0.19% |
| 2007 | 14.95 Billion USD | 7.34% |
| 2006 | 14.48 Billion USD | 26.18% |
| 2005 | 11.64 Billion USD | 116.84% |
| 2004 | - USD | 24.11% |
| 2003 | 16.77 Billion USD | 26.27% |
| 2002 | 13.28 Billion USD | 27.17% |
| 2001 | 10.44 Billion USD | -39.68% |
| 2000 | 17.31 Billion USD | 40.19% |
| 1999 | 12.35 Billion USD | 11.55% |
| 1998 | 11.07 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 12.19 Billion USD | -6.72% |
| 2024 Q2 | 13.07 Billion USD | 8.67% |
| 2024 Q1 | 12.03 Billion USD | 6.35% |
| 2023 Q1 | 11.38 Billion USD | 15.73% |
| 2023 Q2 | 12.06 Billion USD | 5.99% |
| 2023 FY | 154.04 Billion USD | 7.3% |
| 2023 Q3 | 12.24 Billion USD | 1.45% |
| 2023 Q4 | 11.31 Billion USD | -7.6% |
| 2022 Q2 | 35.56 Billion USD | 1.0% |
| 2022 Q1 | 35.21 Billion USD | 5.08% |
| 2022 Q3 | 36.5 Billion USD | 2.64% |
| 2022 Q4 | 36.28 Billion USD | -0.6% |
| 2022 FY | 143.56 Billion USD | 12.38% |
| 2021 Q1 | 30.07 Billion USD | 2.63% |
| 2021 Q2 | 31.23 Billion USD | 3.87% |
| 2021 Q4 | 33.51 Billion USD | 1.78% |
| 2021 Q3 | 32.92 Billion USD | 5.4% |
| 2021 FY | 127.74 Billion USD | 13.13% |
| 2020 Q4 | 29.3 Billion USD | 1.26% |
| 2020 Q3 | 28.93 Billion USD | 7.02% |
| 2020 FY | 112.91 Billion USD | 10.46% |
| 2020 Q1 | 27.63 Billion USD | 5.25% |
| 2020 Q2 | 27.03 Billion USD | -2.16% |
| 2019 Q3 | 25.92 Billion USD | 2.21% |
| 2019 Q1 | 24.66 Billion USD | 5.53% |
| 2019 Q2 | 25.36 Billion USD | 2.85% |
| 2019 Q4 | 26.25 Billion USD | 1.27% |
| 2019 FY | 102.22 Billion USD | 10.98% |
| 2018 Q4 | 23.37 Billion USD | 0.52% |
| 2018 FY | 92.1 Billion USD | 2.29% |
| 2018 Q3 | 23.25 Billion USD | 1.34% |
| 2018 Q2 | 22.94 Billion USD | 1.8% |
| 2018 Q1 | 22.53 Billion USD | -0.63% |
| 2017 Q2 | 22.4 Billion USD | -0.53% |
| 2017 Q3 | 22.42 Billion USD | 0.08% |
| 2017 Q4 | 22.68 Billion USD | 1.13% |
| 2017 FY | 90.03 Billion USD | 6.1% |
| 2017 Q1 | 22.52 Billion USD | 3.74% |
| 2016 Q3 | 21.4 Billion USD | -0.24% |
| 2016 Q1 | 20.28 Billion USD | 0.5% |
| 2016 FY | 84.86 Billion USD | 7.21% |
| 2016 Q4 | 21.71 Billion USD | 1.45% |
| 2016 Q2 | 21.45 Billion USD | 5.76% |
| 2015 Q4 | 20.18 Billion USD | 1.44% |
| 2015 Q3 | 19.9 Billion USD | -0.57% |
| 2015 Q2 | 20.01 Billion USD | 5.06% |
| 2015 FY | 79.15 Billion USD | 7.15% |
| 2015 Q1 | 19.05 Billion USD | 0.35% |
| 2014 FY | 73.87 Billion USD | 4.01% |
| 2014 Q4 | 18.98 Billion USD | 2.3% |
| 2014 Q3 | 18.55 Billion USD | 0.45% |
| 2014 Q2 | 18.47 Billion USD | 3.44% |
| 2014 Q1 | 17.85 Billion USD | 1.64% |
| 2013 Q2 | 17.79 Billion USD | 0.61% |
| 2013 FY | 71.02 Billion USD | 15.09% |
| 2013 Q4 | 17.57 Billion USD | -2.22% |
| 2013 Q3 | 17.96 Billion USD | 0.98% |
| 2013 Q1 | 17.68 Billion USD | -71.28% |
| 2012 Q2 | 15.4 Billion USD | -0.05% |
| 2012 Q3 | 15.35 Billion USD | -0.35% |
| 2012 Q4 | 61.57 Billion USD | 301.05% |
| 2012 FY | 61.71 Billion USD | 1.65% |
| 2012 Q1 | 15.41 Billion USD | 0.64% |
| 2011 Q4 | 15.31 Billion USD | -0.52% |
| 2011 Q3 | 15.39 Billion USD | 1.97% |
| 2011 Q2 | 15.1 Billion USD | 1.39% |
| 2011 Q1 | 14.89 Billion USD | 1.68% |
| 2011 FY | 60.71 Billion USD | 3.25% |
| 2010 Q2 | 14.45 Billion USD | -4.25% |
| 2010 Q3 | 14.57 Billion USD | 0.8% |
| 2010 Q4 | 14.64 Billion USD | 0.52% |
| 2010 FY | 58.8 Billion USD | -9.57% |
| 2010 Q1 | 15.09 Billion USD | -20.73% |
| 2009 Q4 | 19.04 Billion USD | 23.48% |
| 2009 Q2 | 15.41 Billion USD | 1.78% |
| 2009 Q1 | 15.14 Billion USD | 0.49% |
| 2009 FY | 65.02 Billion USD | 6.17% |
| 2009 Q3 | 15.42 Billion USD | 0.08% |
| 2008 Q4 | 15.06 Billion USD | 0.73% |
| 2008 Q2 | 15.66 Billion USD | 0.73% |
| 2008 Q3 | 14.96 Billion USD | -4.51% |
| 2008 Q1 | 15.55 Billion USD | -0.05% |
| 2008 FY | 61.25 Billion USD | 0.19% |
| 2007 Q4 | 15.56 Billion USD | 2.15% |
| 2007 Q3 | 15.23 Billion USD | -0.17% |
| 2007 Q2 | 15.25 Billion USD | 1.2% |
| 2007 Q1 | 15.07 Billion USD | 3.6% |
| 2007 FY | 61.13 Billion USD | 7.34% |
| 2006 Q4 | 14.55 Billion USD | 0.9% |
| 2006 Q3 | 14.42 Billion USD | 1.94% |
| 2006 Q2 | 14.15 Billion USD | 2.4% |
| 2006 Q1 | 13.81 Billion USD | 20.88% |
| 2006 FY | 56.95 Billion USD | 26.18% |
| 2005 Q2 | 11.29 Billion USD | 1.8% |
| 2005 Q3 | 11.3 Billion USD | 0.05% |
| 2005 FY | 45.13 Billion USD | 116.84% |
| 2005 Q4 | 11.43 Billion USD | 1.13% |
| 2005 Q1 | 11.09 Billion USD | 62.43% |
| 2004 Q2 | 4.6 Billion USD | 0.66% |
| 2004 Q1 | 4.57 Billion USD | 6.5% |
| 2004 FY | 20.81 Billion USD | 24.11% |
| 2004 Q4 | 6.83 Billion USD | 42.28% |
| 2004 Q3 | 4.8 Billion USD | 4.31% |
| 2003 Q3 | 4.26 Billion USD | 4.57% |
| 2003 Q2 | 4.07 Billion USD | 0.3% |
| 2003 FY | 16.77 Billion USD | 26.27% |
| 2003 Q4 | 4.29 Billion USD | 0.78% |
| 2003 Q1 | 4.06 Billion USD | 1.83% |
| 2002 Q3 | 3.54 Billion USD | 22.09% |
| 2002 FY | 13.28 Billion USD | 27.17% |
| 2002 Q2 | 2.9 Billion USD | 3.12% |
| 2002 Q1 | 2.81 Billion USD | 5.64% |
| 2002 Q4 | 3.99 Billion USD | 12.7% |
| 2001 FY | 10.44 Billion USD | -39.68% |
| 2001 Q3 | 2.66 Billion USD | 0.0% |
| 2001 Q4 | 2.66 Billion USD | -0.06% |
| 2000 FY | 17.31 Billion USD | 40.19% |
| 1999 FY | 12.35 Billion USD | 11.55% |
| 1998 FY | 11.07 Billion USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -23201.693% |
| Accuray Incorporated | 143.12 Million USD | -32746.333% |
| Align Technology, Inc. | 2.72 Billion USD | -1628.205% |
| AxoGen, Inc. | 127.87 Million USD | -36662.751% |
| Boston Scientific Corporation | 9.84 Billion USD | -377.307% |
| CVS Health Corporation | 54.43 Billion USD | 13.634% |
| Cardinal Health, Inc. | 7.41 Billion USD | -534.071% |
| Centene Corporation | 153.99 Billion USD | 69.474% |
| DaVita Inc. | 3.82 Billion USD | -1130.49% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 14.63% |
| Hologic, Inc. | 2.23 Billion USD | -2000.724% |
| Humana Inc. | 106.44 Billion USD | 55.834% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -2046.605% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | -1297.07% |
| Masimo Corporation | 1 Billion USD | -4584.604% |
| McKesson Corporation | 12.58 Billion USD | -273.57% |
| Patterson Companies, Inc. | 1.38 Billion USD | -3305.924% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | -1487.639% |
| ResMed Inc. | 2.6 Billion USD | -1701.99% |
| Henry Schein, Inc. | 3.65 Billion USD | -1187.592% |
| Teladoc Health, Inc. | 1.84 Billion USD | -2451.585% |
| Universal Health Services, Inc. | 1.17 Billion USD | -3899.554% |
| Veeva Systems Inc. | 1.68 Billion USD | -2687.625% |
| Baxter International Inc. | 4.97 Billion USD | -844.925% |
| Becton, Dickinson and Company | 8.82 Billion USD | -432.812% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | -893.974% |
| Danaher Corporation | 14.12 Billion USD | -232.72% |
| Stryker Corporation | 13.05 Billion USD | -260.009% |
| Medtronic plc | 21.27 Billion USD | -120.984% |